Harmanci, A. Et Al. 2006. Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in type 1 diabetes - Evidence for normal fibrinolytic state. JOURNAL OF DIABETES AND ITS COMPLICATIONS , vol.20, no.1 , 40-44.

Harmanci, A., Kandemir, N., Dagdelen, S., Gonc, N., Buyukasik, Y., Alikasifoglu, A., ... Kirazli, S.(2006). Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in type 1 diabetes - Evidence for normal fibrinolytic state. JOURNAL OF DIABETES AND ITS COMPLICATIONS , vol.20, no.1, 40-44.

Harmanci, A Et Al. "Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in type 1 diabetes - Evidence for normal fibrinolytic state," JOURNAL OF DIABETES AND ITS COMPLICATIONS , vol.20, no.1, 40-44, 2006

Harmanci, A Et Al. "Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in type 1 diabetes - Evidence for normal fibrinolytic state." JOURNAL OF DIABETES AND ITS COMPLICATIONS , vol.20, no.1, pp.40-44, 2006

Harmanci, A. Et Al. (2006) . "Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in type 1 diabetes - Evidence for normal fibrinolytic state." JOURNAL OF DIABETES AND ITS COMPLICATIONS , vol.20, no.1, pp.40-44.

@article{article, author={A Harmanci Et Al. }, title={Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in type 1 diabetes - Evidence for normal fibrinolytic state}, journal={JOURNAL OF DIABETES AND ITS COMPLICATIONS}, year=2006, pages={40-44} }